,file,ref_number,ref_text,doi,doi_url
0,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_17,[1],"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D; ESMO Guidelines Working Group. 2014. Ann Oncol. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.",10.1093/annonc/mdu260,https://doi.org/10.1093/annonc/mdu260
1,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_17,[2],"Longley DB, Harkin DP, Johnston PG. 2003. Nat Rev Cancer. 5-fluorouracil: mechanisms of action and clinical strategies.",10.1038/nrc1074,https://doi.org/10.1038/nrc1074
2,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_17,[3],"Cunningham D, Humblet Y, Siena S, et al. 2004. N Engl J Med. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.",10.1056/nejmoa033025,https://doi.org/10.1056/nejmoa033025
3,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_17,[4],"Le DT, Uram JN, Wang H, et al. 2015. N Engl J Med. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.",10.1007/s11725-015-0588-4,https://doi.org/10.1007/s11725-015-0588-4
4,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_17,[5],Compton CC. 2007. Arch Pathol Lab Med. Prognostic factors in cancer: role of the pathologist.,10.3109/9781439807231-4,https://doi.org/10.3109/9781439807231-4
5,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_17,[6],"Chaffer CL, Weinberg RA. 2011. Science. A perspective on cancer cell metastasis.",10.1126/science.1203543,https://doi.org/10.1126/science.1203543
